Switching Anti VEGF in AMD Aflibercept Review

In this Issue:

This is our  most recent review of alternative strategies for treatment resistant AMD and predominantly the impact of switching to alterative anti-VEGF agents, dose escalation and combination therapy.

Commentary has been provided by Associate Professor Lawrence Lee.

Please login below to download this issue (PDF)